Diamond Biotechnology Co., Ltd engages in the research, development, manufacture, and sale of health care products and medical consumables in Taiwan and internationally. The company offers Miracle Thread, an absorbable synthetic surgical suture device made of polydioxanone; UTIMS, a high-intensity focused ultrasound; Letybo, a frozen crystal injection; TEOSYAL RHA invisible resilient hyaluronic acid; Ronkyla, a sodium deoxycholate injection; S+DIAMOND skincare products. It also sells and leases medical equipment. The company was founded in 2014 and is based in Taipei, Taiwan.
Frequently asked questions
What sector does Diamond Biotechnology Co., Ltd (6815) operate in?
Diamond Biotechnology Co., Ltd belongs to the Other sector and operates in the Medical Devices industry.
What is Diamond Biotechnology Co., Ltd (6815) current stock price?
As of the latest data, Diamond Biotechnology Co., Ltd stock price is NT$24.95, with a previous close of NT$24.95.
What is Diamond Biotechnology Co., Ltd (6815) current market capitalization?
Diamond Biotechnology Co., Ltd market cap is approximately 985.35 million.
What is Diamond Biotechnology Co., Ltd (6815) Earnings Per Share (EPS)?
The trailing EPS is -NT$1.78.
Does Diamond Biotechnology Co., Ltd (6815) pay dividends?
Yes. Diamond Biotechnology Co., Ltd pays annual dividends with an annualized yield of 0.78% and an estimated annual payout of NT$0.20 per share.
When is the next ex-dividend date for Diamond Biotechnology Co., Ltd (6815)?
The next ex-dividend date is scheduled for August 27, 2026.
What is Diamond Biotechnology Co., Ltd (6815) beta (volatility) score?
Diamond Biotechnology Co., Ltd has a beta of 0.351, indicating lower volatility than the overall market.
